44 / 160
44
42. Rantala AK, Jaakkola MS, Mäkikyrö EM, Hugg TT, Jaakkola JJ.
Early Respiratory Infections and the Development of Asthma in
the First 27 Years of Life. Am J Epidemiol. 2015;182:615-23.
43. Mallol J, Aguirre V, Wandalsen G. Common cold decreases
lung function in infants with recurrent wheezing. Allergol
Immunopathol 2010;38:110-4.
44. Garcia-Marcos L, Mallol J, Solé D, Brand PL, EISL Study Group.
International study of wheezing in infants: risk factors in
affluent and non-affluent countries during the first year of life.
Pediatr Allergy Immunol. 2010;21:878-88.
45. Silvestri M, Franchi S, Pistorio A, Petecchia L, Rusconi F. Smoke
exposure, wheezing, and asthma development: a systematic
review and meta-analysis in unselected birth cohorts. Pediatr
Pulmonol. 2015;50:353-62.
46. Brunst KJ, Ryan PH, Brokamp C, Bernstein D, Reponen T, et al.
Timing and Duration of Traffic-related Air Pollution Exposure
and the Risk for Childhood Wheeze and Asthma. Am J Respir
Crit Care Med. 2015;192:421-7.
47. Mallol J. Asma del lactante: bases para el diagnóstico y
tratamiento. Pulmão RJ 2013;22:48-52
48. Brand PL. Inhaled corticosteroids should be the first line of
treatment for children with asthma. Paediatr Respir Rev.
2011;12:245-9.
49. Rau JL, Coppolo DP, Nagel MW, Avvakoumova VI, Doyle CC, et
al. The importance of nonelectrostatic materials in holding
chambers for delivery of hydrofluoroalkane albuterol. Respir
Care. 2006;51:503-10.
50. van Aalderen WM, Grigg J, Guilbert TW, Roche N, Israel E,
et al. Small-particle Inhaled Corticosteroid as First-line or
Step-up Controller Therapy in Childhood Asthma. J Allergy Clin
Immunol Pract. 2015;3:721-31
51. van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF.
Safety, tolerability, and exploratory efficacy of montelukast
in 6- to 24-month-old patients with asthma. Curr Med Res
Opin. 2005;21:971-9.
52. Pelkonen AS, Malmström K, Sarna S, Kajosaari M, Klemola
T, et al. The effect of montelukast on respiratory symp¬toms
and lung function in wheezy infants. Eur Respir J 2013;41:
664-70.
53. Brodlie M, Gupta A, Rodriguez-Martinez CE, Castro-Rodriguez
JA, Ducharme FM, McKean MC. Leukotriene receptor
antagonists as maintenance and intermittent therapy for
episodic viral wheeze in children. Cochrane Database Syst Rev.
2015 Oct 19;10:CD008202.
54. Wallerstedt SM, Brunlöf G, Sundström A, Eriksson AL.
Montelukast and psychiatric disorders in children.
Pharmacoepidemiol Drug Saf. 2009;18:858-64.
55. Erdem SB, Nacaroglu HT, Unsal Karkiner CS, Gunay I, Can D.
Side Effects of Leukotriene Receptor Antagonists in Asthmatic
Children. Iran J Pediatr. 2015;25:e3313.
56. Raissy HH, Blake K. Macrolides for Acute Wheezing Episodes
in Preschool Children. Pediatr Allergy Immunol Pulmonol.
2016;29:100-103.Free PMC Article.
57. Stokholm J, Chawes BL, Vissing NH, Bjarnadóttir E, Pedersen TM,
et al. Azithromycin for episodes with asthma-like symptoms
in young children aged 1–3 years: a randomised, doubleblind,
placebo-controlled trial. Lancet Respir Med 2016; 4:19–26
58. Bacharier LB, Guilbert TW, Mauger DT, et al. National Heart,
Lung, and Blood Institute’s AsthmaNet. Early administration of
azithromycin and prevention of severe lower respiratory tract
illnesses in preschool children with a history of such illnesses:
a randomized clinical trial. JAMA 2015; 314:2034–2044.
[REV. MED. CLIN. CONDES - 2017; 28(1) 37-44]